Cargando…
Artificial intelligence in COVID-19 drug repurposing
Drug repurposing or repositioning is a technique whereby existing drugs are used to treat emerging and challenging diseases, including COVID-19. Drug repurposing has become a promising approach because of the opportunity for reduced development timelines and overall costs. In the big data era, artif...
Autores principales: | Zhou, Yadi, Wang, Fei, Tang, Jian, Nussinov, Ruth, Cheng, Feixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500917/ https://www.ncbi.nlm.nih.gov/pubmed/32984792 http://dx.doi.org/10.1016/S2589-7500(20)30192-8 |
Ejemplares similares
-
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
por: Fang, Jiansong, et al.
Publicado: (2022) -
Application of Artificial Intelligence in COVID-19 drug repurposing
por: Mohanty, Sweta, et al.
Publicado: (2020) -
Artificial intelligence approach fighting COVID-19 with repurposing drugs
por: Ke, Yi-Yu, et al.
Publicado: (2020) -
A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19
por: Ahmed, Faheem, et al.
Publicado: (2022) -
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
por: Zhou, Yadi, et al.
Publicado: (2020)